415 related articles for article (PubMed ID: 25313507)
1. SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking.
Bowton E; Saunders C; Reddy IA; Campbell NG; Hamilton PJ; Henry LK; Coon H; Sakrikar D; Veenstra-VanderWeele JM; Blakely RD; Sutcliffe J; Matthies HJ; Erreger K; Galli A
Transl Psychiatry; 2014 Oct; 4(10):e464. PubMed ID: 25313507
[TBL] [Abstract][Full Text] [Related]
2. Anomalous dopamine release associated with a human dopamine transporter coding variant.
Mazei-Robison MS; Bowton E; Holy M; Schmudermaier M; Freissmuth M; Sitte HH; Galli A; Blakely RD
J Neurosci; 2008 Jul; 28(28):7040-6. PubMed ID: 18614672
[TBL] [Abstract][Full Text] [Related]
3. The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants.
Mergy MA; Gowrishankar R; Gresch PJ; Gantz SC; Williams J; Davis GL; Wheeler CA; Stanwood GD; Hahn MK; Blakely RD
Proc Natl Acad Sci U S A; 2014 Nov; 111(44):E4779-88. PubMed ID: 25331903
[TBL] [Abstract][Full Text] [Related]
4. Regulation of dopamine transporter trafficking by intracellular amphetamine.
Kahlig KM; Lute BJ; Wei Y; Loland CJ; Gether U; Javitch JA; Galli A
Mol Pharmacol; 2006 Aug; 70(2):542-8. PubMed ID: 16684900
[TBL] [Abstract][Full Text] [Related]
5. Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier.
Kahlig KM; Javitch JA; Galli A
J Biol Chem; 2004 Mar; 279(10):8966-75. PubMed ID: 14699142
[TBL] [Abstract][Full Text] [Related]
6. Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation.
Sakrikar D; Mazei-Robison MS; Mergy MA; Richtand NW; Han Q; Hamilton PJ; Bowton E; Galli A; Veenstra-Vanderweele J; Gill M; Blakely RD
J Neurosci; 2012 Apr; 32(16):5385-97. PubMed ID: 22514303
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder.
Bowton E; Saunders C; Erreger K; Sakrikar D; Matthies HJ; Sen N; Jessen T; Colbran RJ; Caron MG; Javitch JA; Blakely RD; Galli A
J Neurosci; 2010 Apr; 30(17):6048-57. PubMed ID: 20427663
[TBL] [Abstract][Full Text] [Related]
8. Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.
Binda F; Dipace C; Bowton E; Robertson SD; Lute BJ; Fog JU; Zhang M; Sen N; Colbran RJ; Gnegy ME; Gether U; Javitch JA; Erreger K; Galli A
Mol Pharmacol; 2008 Oct; 74(4):1101-8. PubMed ID: 18617632
[TBL] [Abstract][Full Text] [Related]
9. N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux.
Khoshbouei H; Sen N; Guptaroy B; Johnson L'; Lund D; Gnegy ME; Galli A; Javitch JA
PLoS Biol; 2004 Mar; 2(3):E78. PubMed ID: 15024426
[TBL] [Abstract][Full Text] [Related]
10. Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder.
Mazei-Robison MS; Couch RS; Shelton RC; Stein MA; Blakely RD
Neuropharmacology; 2005 Nov; 49(6):724-36. PubMed ID: 16171832
[TBL] [Abstract][Full Text] [Related]
11. Single Quantum Dot Imaging Reveals PKCβ-Dependent Alterations in Membrane Diffusion and Clustering of an Attention-Deficit Hyperactivity Disorder/Autism/Bipolar Disorder-Associated Dopamine Transporter Variant.
Thal LB; Tomlinson ID; Quinlan MA; Kovtun O; Blakely RD; Rosenthal SJ
ACS Chem Neurosci; 2019 Jan; 10(1):460-471. PubMed ID: 30153408
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic Ric GTPase activity impacts amphetamine sensitivity and sleep quality in a dopamine transporter-dependent manner in Drosophila melanogaster.
Fagan RR; Kearney PJ; Luethi D; Bolden NC; Sitte HH; Emery P; Melikian HE
Mol Psychiatry; 2021 Dec; 26(12):7793-7802. PubMed ID: 34471250
[TBL] [Abstract][Full Text] [Related]
13. Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution.
Garcia BG; Wei Y; Moron JA; Lin RZ; Javitch JA; Galli A
Mol Pharmacol; 2005 Jul; 68(1):102-9. PubMed ID: 15795321
[TBL] [Abstract][Full Text] [Related]
14. Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors.
DiCarlo GE; Aguilar JI; Matthies HJ; Harrison FE; Bundschuh KE; West A; Hashemi P; Herborg F; Rickhag M; Chen H; Gether U; Wallace MT; Galli A
J Clin Invest; 2019 May; 129(8):3407-3419. PubMed ID: 31094705
[TBL] [Abstract][Full Text] [Related]
15. De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder.
Hamilton PJ; Campbell NG; Sharma S; Erreger K; Herborg Hansen F; Saunders C; Belovich AN; ; Sahai MA; Cook EH; Gether U; McHaourab HS; Matthies HJ; Sutcliffe JS; Galli A
Mol Psychiatry; 2013 Dec; 18(12):1315-23. PubMed ID: 23979605
[TBL] [Abstract][Full Text] [Related]
16. Amphetamine activates calcium channels through dopamine transporter-mediated depolarization.
Cameron KN; Solis E; Ruchala I; De Felice LJ; Eltit JM
Cell Calcium; 2015 Nov; 58(5):457-66. PubMed ID: 26162812
[TBL] [Abstract][Full Text] [Related]
17. Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease.
Herborg F; Jensen KL; Tolstoy S; Arends NV; Posselt LP; Shekar A; Aguilar JI; Lund VK; Erreger K; Rickhag M; Lycas MD; Lonsdale MN; Rahbek-Clemmensen T; Sørensen AT; Newman AH; Løkkegaard A; Kjærulff O; Werge T; ; Møller LB; Matthies HJ; Galli A; Hjermind LE; Gether U
JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34375312
[TBL] [Abstract][Full Text] [Related]
18. Is dopamine transporter-mediated dopaminergic signaling in the retina a noninvasive biomarker for attention-deficit/ hyperactivity disorder? A study in a novel dopamine transporter variant Val559 transgenic mouse model.
Dai H; Jackson CR; Davis GL; Blakely RD; McMahon DG
J Neurodev Disord; 2017 Dec; 9(1):38. PubMed ID: 29281965
[TBL] [Abstract][Full Text] [Related]
19. An N-terminal threonine mutation produces an efflux-favorable, sodium-primed conformation of the human dopamine transporter.
Fraser R; Chen Y; Guptaroy B; Luderman KD; Stokes SL; Beg A; DeFelice LJ; Gnegy ME
Mol Pharmacol; 2014 Jul; 86(1):76-85. PubMed ID: 24753048
[TBL] [Abstract][Full Text] [Related]
20. Region-Specific Regulation of Presynaptic Dopamine Homeostasis by D
Gowrishankar R; Gresch PJ; Davis GL; Katamish RM; Riele JR; Stewart AM; Vaughan RA; Hahn MK; Blakely RD
J Neurosci; 2018 Jun; 38(23):5302-5312. PubMed ID: 29739866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
